Skip to main content
Log in

Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients

  • Original Article
  • Published:
Transplant International

Abstract

Besides immunosuppression and UV radiation, human papillomavirus (HPV) infection was also suggested to be involved in the development of non-melanoma skin cancer, the most common malignancy after transplantation. In this study we used a comprehensive PCR assay to analyze the prevalence of individual HPV types in different skin lesions from transplant and non-transplant patients. HPV DNA was detected more frequently in squamous cell carcinomas (SCCs) of transplant recipients (75%) than the same lesion was in non-immunosuppressed patients (47%). Similar HPV prevalences were found in cutaneous warts (91% vs 94%), pre-malignant skin tumors (38% vs 36%), and normal skin specimens (17% vs 16%) of both patient populations. Overall, more than 40 different HPV types were identified. HPV types 5 and 8 were found more frequently in SCCs (26%) than in pre-cancerous (5%) or benign lesions (1%). All HPV 5- and HPV 8-positive SCCs were from immunosuppressed patients, indicating that infection with HPV 5 and HPV 8 may present an increased risk of SCC development in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402

    PubMed  Google Scholar 

  2. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J (1995) Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33:690–695

    CAS  PubMed  Google Scholar 

  3. Berkhout RJM, Bouwes-Bavinck JN, ter Schegget J (2000) Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 38:2087–2096

    CAS  PubMed  Google Scholar 

  4. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L (1995) Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer 60:183–189

    CAS  PubMed  Google Scholar 

  5. Blessing K, McLaren KM, Benton EC, Barr BB, Bunney MH, Smith FW, Beveridge GW (1989) Histopathology of skin lesions in renal allograft recipients: an assessment of viral features and dysplasia. Histopathology 14:129–139

    CAS  PubMed  Google Scholar 

  6. Chan SY, Delius H, Halpern AL, Bernard HU (1995) Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69:3074–3083

    CAS  PubMed  Google Scholar 

  7. De Jong Tieben LM, Berkhout RJM, Smits HL, Bouwes-Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J (1995) High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 105:367–371

    PubMed  Google Scholar 

  8. De Villiers EM, Lavergne D, McLaren KM, Benton EC (1997) Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 73:356–361

    Article  PubMed  Google Scholar 

  9. Harwood CA, McGregor JM, Proby CM, Breuer J (1999) Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 52:249–253

    CAS  PubMed  Google Scholar 

  10. Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, McGregor JM, Proby CM, Breuer J (1999) Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 37:3545–3555

    CAS  PubMed  Google Scholar 

  11. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 61:289–297

    Article  CAS  PubMed  Google Scholar 

  12. Kwok S (1990) Procedures to minimize PCR-product carry-over. In: Innis M, Gelfand D, Sninsky J, White T (eds) PCR protocols: a guide to methods and applications. Academic Press, San Diego, pp 356–367

    Google Scholar 

  13. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214

    CAS  Google Scholar 

  14. Meyer T, Arndt R, Stockfleth E, Flammann HT, Wolf H, Reischl U (1995) Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 19:632–639

    PubMed  Google Scholar 

  15. Meyer T, Arndt R, Christophers E, Stockfleth E (2000) Frequency and spectrum of HPV types detected in cutaneous squamous cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology 201:204–211

    Article  CAS  PubMed  Google Scholar 

  16. Nindl I, Jacobs M, Walboomers JMM, Pfister H, Meyer T, Stockfleth E, Kläs R, von Knebel-Döberitz M, Schneider A, Dürst M (1999) Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical smears. Int J Cancer 81:666–668

    Article  CAS  PubMed  Google Scholar 

  17. Orth G (1987) Epidermodysplasia verruciformis. In: Salzman NP, Howley PM (eds) The papovaviridae, the papillomaviruses. Plenum Press, New York, pp 199–235

  18. Pfister H, ter Schegget J (1997) Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 15:335–348

    Google Scholar 

  19. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY

  20. Schiller JT (1999) Papillomavirus-like particle vaccines for cervical cancer. Mol Med Today 5:209–215

    Article  CAS  PubMed  Google Scholar 

  21. Shamanin V, Glover M, Rausch C, Proby CM, Leigh IM, zur Hausen H, de Villiers EM (1994) Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 54:4610–4613

    CAS  PubMed  Google Scholar 

  22. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B (1993) Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 101:286–291

    Google Scholar 

  23. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JA, Bird CC (1994) Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 69:222–229

    CAS  PubMed  Google Scholar 

  24. Stockfleth E, Ulrich C, Meyer T, Arndt R, Christophers E (2001) Skin diseases following organ transplantation—risk factors and new therapeutic approaches. Transplant Proc 33:1848–1853

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the DKH, Germany (Grant No. 70–2588)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Meyer.

About this article

Cite this article

Meyer, T., Arndt, R., Nindl, I. et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int 16, 146–153 (2003). https://doi.org/10.1007/s00147-002-0525-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00147-002-0525-7

Keywords

Navigation